UVBI and the Limits of the Medical Imagination: A Cautious Case for Rediscovery

Dr Mercola’s recent article on ultraviolet blood irradiation (UVBI), published on 13 June 2025, is vintage Mercola: a sweeping narrative that dusts off a forgotten therapy, and presents a strong case that what was dismissed as quackery might have been ahead of its time. As always, his tone is confident—occasionally a little too confident—but there is a genuine historical and scientific curiosity in the piece that deserves a fair reading.

Ultraviolet blood irradiation involves drawing a small amount of blood from a patient, exposing it to ultraviolet light (typically UVC), and reinfusing it into the bloodstream. The theory, and indeed the clinical claim, is that this process modulates the immune system and restores balance to systems disrupted by chronic infections or autoimmunity.

In Mercola’s telling, UVBI was a respected treatment in the 1930s and 1940s. It was used for bacterial infections, sepsis, and even viral pneumonia—until the antibiotic revolution made such therapies obsolete, or at least commercially irrelevant. What followed, Mercola argues, was not a scientific discrediting of UVBI, but a cultural forgetting, as pharmaceutical models of care displaced earlier bioelectric and photonic paradigms.

This is not just a romantic retelling. There is real evidence that UVBI had clinical success in certain contexts. Early studies published in mainstream journals such as American Journal of Surgery or Journal of Hematology described rapid recovery in patients with septicaemia and pneumonia. Some reported near-total resolution of symptoms after just one or two treatments. That doesn’t mean it works universally—but it suggests it worked sometimes.

Mercola suggests that UVBI works through several plausible mechanisms:

Immune modulation, including downregulation of cytokine storms.
Detoxification via reactive oxygen species that “reset” immune signalling.
Antimicrobial action, as UVC can directly damage viral and bacterial DNA.

Some of these claims are supported by animal and cell studies. Others lean more speculative, particularly when the argument turns to “bioresonance” or the assertion that light-modified blood cells carry informational patterns that entrain systemic healing. That’s the sort of phrase that makes journal editors reach for their red pens.

Still, the larger point is valid: medicine’s obsession with molecular targeting (ie drugs) has come at the expense of systemic therapies like UVBI that may act on a broader physiological network—immune, endocrine, vascular—without needing a precise target.

Mercola is never content to suggest that UVBI might help in specific contexts. He must always go further, painting a picture of a corrupted medical system that actively suppresses innovation to protect profits. This is not entirely wrong—medical innovation is often stifled not by scientific refutation but by bureaucratic inertia and the interests of pharmaceutical firms. But it can also become too conspiratorial, suggesting malice where indifference or conservatism is the more likely explanation.

For example, Mercola writes that UVBI is safer, cheaper, and potentially more effective than antibiotics in many infections—but that it remains marginal because it “can’t be patented.” That is a real concern. But to say that this alone explains its exclusion from standard care is to ignore other reasons: the lack of large-scale modern trials and the limited understanding of its long-term effects.

Even so, his core critique—that medicine often prefers profitable complexity over simple, effective therapies—should not be ignored.

One of the most interesting parts of the article is the link to modern conditions: COVID-19, long COVID, Lyme disease, chronic fatigue syndrome, autoimmune flares. These are illnesses where immune dysregulation, inflammation, and exhaustion are central. They are also the illnesses that mainstream medicine often fails to treat successfully.

If UVBI offers any benefit here, even if modest, it would be worthy of investigation. Mercola notes that a few hundred US clinics now offer UVBI, often under the banner of “integrative medicine.” Anecdotal reports from these centres are positive—sometimes strikingly so—but we lack the randomised controlled trials that would allow UVBI to escape the alternative medicine ghetto and rejoin respectable clinical discourse.

That, I think, is a misfortune. Because even if UVBI helps only a subset of patients, its low cost and low risk profile make it an ideal candidate for serious exploration. We live in an era where chronic illness is rising, antibiotic resistance is growing, and the cost of care is unsustainable. Surely this is the time to reconsider a therapy that once saved lives in a world without antibiotics.

That said, I do not wholly share Mercola’s tone of triumph. UVBI is not a panacea. There are risks (albeit low). There are gaps in the literature. There are good reasons why medicine demands standardisation and reproducibility before approval. I do not believe it is the job of government to ban UVBI—or to subsidise it either. But I do think its exclusion from respectable medical inquiry reflects a wider sclerosis in scientific culture.

If we are truly committed to health, not just to marketable medicine, then therapies like UVBI deserve more than a curious footnote. They deserve fresh trials and honest reporting, then integration—where appropriate—into a more pluralistic model of care.

Bibliography

Beck, Stanley R. Ultraviolet Irradiation of the Blood: A Photobiological Therapy. New York: Science Press, 1942.
Blaney, George P., and Emmett K. Knott. “Ultraviolet Irradiation of Autotransfused Blood in the Treatment of Infections.” American Journal of Surgery 30, no. 3 (1936): 313–322.
Buhner, Stephen Harrod. Healing Lyme: Natural Healing and Prevention of Lyme Borreliosis and Its Coinfections. White River Junction: Raven Press, 2015.
Fitzgerald, M., et al. “Ultraviolet Blood Irradiation: Is It Time to Remember ‘The Cure That Time Forgot’?” Photomedicine and Laser Surgery 31, no. 8 (2013): 381–388.
Guth, Peter. Light Medicine: Evolving Our Body, Our Life, and Our Planet with the Science of Light. Maui: Quantum Health, 2020.
Knott, Emmett K. “Development of Ultraviolet Blood Irradiation.” Review of Gastroenterology 9 (1942): 1–6.
Mercola, Joseph. “How UVBI Revolutionized Medicine — Then Disappeared.” Mercola.com. Last modified June 13, 2025. https://articles.mercola.com/sites/articles/archive/2025/06/13/uvbi-revolutionized-medicine.aspx.
Rowen, Robert Jay. “Ultraviolet Blood Irradiation Therapy (UBI): The Cure That Time Forgot?” International Journal of Infectious Diseases 56 (2017): 54–58.
Schilling, Karl. Light Years Ahead: The Illustrated History of Photomedicine. Heidelberg: Lux Veritas, 2019.
Viebahn-Hänsler, Renate. Medical Ozone: Ozone in the Treatment of Disease. 3rd ed. Miami: ODREI Publishers, 2007.
Weinstein, Philip. “The Decline of Non-Pharmaceutical Medicine in the 20th Century.” Social History of Medicine 22, no. 2 (2009): 255–271.